| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
|
Gastroenterology
|
2009
|
3.57
|
|
2
|
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
|
Hepatology
|
2008
|
3.52
|
|
3
|
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival.
|
J Clin Oncol
|
2009
|
3.43
|
|
4
|
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
|
Gastroenterology
|
2010
|
2.35
|
|
5
|
Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.
|
JAMA
|
2010
|
1.84
|
|
6
|
Radioembolization with 90Y microspheres: angiographic and technical considerations.
|
Cardiovasc Intervent Radiol
|
2007
|
1.73
|
|
7
|
Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.
|
Radiology
|
2010
|
1.55
|
|
8
|
Cutaneous thermal injury after endovenous laser ablation of the great saphenous vein.
|
J Vasc Interv Radiol
|
2004
|
1.50
|
|
9
|
Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis.
|
J Vasc Interv Radiol
|
2013
|
1.47
|
|
10
|
Optional or permanent: clinical factors that optimize inferior vena cava filter utilization.
|
J Vasc Interv Radiol
|
2012
|
1.46
|
|
11
|
Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic.
|
J Vasc Interv Radiol
|
2010
|
1.46
|
|
12
|
Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
|
Radiology
|
2008
|
1.45
|
|
13
|
Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres.
|
Hepatology
|
2009
|
1.44
|
|
14
|
Primary failure of uterine artery embolization: use of magnetic resonance imaging to select patients for repeated embolization.
|
J Vasc Interv Radiol
|
2005
|
1.43
|
|
15
|
Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review.
|
J Vasc Interv Radiol
|
2009
|
1.43
|
|
16
|
Sustained safety and efficacy of extended-shelf-life (90)Y glass microspheres: long-term follow-up in a 134-patient cohort.
|
Eur J Nucl Med Mol Imaging
|
2013
|
1.42
|
|
17
|
Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials.
|
J Vasc Interv Radiol
|
2013
|
1.41
|
|
18
|
Biliary sequelae following radioembolization with Yttrium-90 microspheres.
|
J Vasc Interv Radiol
|
2008
|
1.33
|
|
19
|
Technical aspects of radioembolization with 90Y microspheres.
|
Tech Vasc Interv Radiol
|
2007
|
1.31
|
|
20
|
Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs.
|
J Vasc Interv Radiol
|
2008
|
1.29
|
|
21
|
Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation.
|
J Hepatol
|
2010
|
1.25
|
|
22
|
Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.
|
Radiographics
|
2008
|
1.25
|
|
23
|
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.
|
Gastroenterology
|
2011
|
1.25
|
|
24
|
A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.
|
J Vasc Interv Radiol
|
2007
|
1.23
|
|
25
|
Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors.
|
J Vasc Interv Radiol
|
2007
|
1.20
|
|
26
|
Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors.
|
J Vasc Interv Radiol
|
2008
|
1.19
|
|
27
|
Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
|
Radiology
|
2008
|
1.19
|
|
28
|
Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
|
Cancer
|
2009
|
1.19
|
|
29
|
Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization.
|
Cardiovasc Intervent Radiol
|
2009
|
1.18
|
|
30
|
Radiology resident interpretations of on-call imaging studies: the incidence of major discrepancies.
|
Acad Radiol
|
2008
|
1.17
|
|
31
|
Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization.
|
Ann Surg Oncol
|
2009
|
1.17
|
|
32
|
Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
|
Cancer
|
2008
|
1.14
|
|
33
|
MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility study.
|
Radiology
|
2008
|
1.11
|
|
34
|
Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors.
|
J Vasc Interv Radiol
|
2007
|
1.10
|
|
35
|
Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection.
|
J Hepatol
|
2013
|
1.08
|
|
36
|
The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases.
|
J Vasc Interv Radiol
|
2009
|
1.06
|
|
37
|
Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
|
Am J Clin Oncol
|
2008
|
1.03
|
|
38
|
Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
|
J Vasc Interv Radiol
|
2008
|
1.03
|
|
39
|
Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
|
J Vasc Interv Radiol
|
2007
|
1.02
|
|
40
|
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.01
|
|
41
|
Four-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results.
|
J Vasc Interv Radiol
|
2008
|
1.00
|
|
42
|
Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival.
|
J Vasc Interv Radiol
|
2009
|
0.98
|
|
43
|
Radiologic findings following Y90 radioembolization for primary liver malignancies.
|
Abdom Imaging
|
2009
|
0.97
|
|
44
|
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.
|
J Hepatol
|
2012
|
0.96
|
|
45
|
Rabbit VX2 tumors as an animal model of uterine fibroids and for uterine artery embolization.
|
J Vasc Interv Radiol
|
2007
|
0.96
|
|
46
|
Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization.
|
World J Gastroenterol
|
2010
|
0.95
|
|
47
|
Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma.
|
J Magn Reson Imaging
|
2010
|
0.94
|
|
48
|
Greater energy delivery improves treatment success of endovenous laser treatment of incompetent saphenous veins.
|
J Vasc Interv Radiol
|
2004
|
0.93
|
|
49
|
Electroporation-mediated transcatheter arterial chemoembolization in the rabbit VX2 liver tumor model.
|
Invest Radiol
|
2012
|
0.89
|
|
50
|
Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.
|
AJR Am J Roentgenol
|
2011
|
0.89
|
|
51
|
90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
|
J Vasc Interv Radiol
|
2007
|
0.89
|
|
52
|
Fibrin cap disruption: an adjunctive technique for inferior vena cava filter retrieval.
|
J Vasc Interv Radiol
|
2012
|
0.88
|
|
53
|
Hepatic abscess after yttrium-90 radioembolization for islet-cell tumor hepatic metastasis.
|
Cardiovasc Intervent Radiol
|
2009
|
0.88
|
|
54
|
MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
|
J Vasc Interv Radiol
|
2008
|
0.87
|
|
55
|
Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization.
|
J Vasc Interv Radiol
|
2010
|
0.87
|
|
56
|
Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors.
|
ACS Nano
|
2013
|
0.87
|
|
57
|
The effect of pelvic MR imaging on the diagnosis and treatment of women with presumed symptomatic uterine fibroids.
|
J Vasc Interv Radiol
|
2002
|
0.86
|
|
58
|
Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.86
|
|
59
|
Development of a VX2 pancreatic cancer model in rabbits: a pilot study.
|
J Vasc Interv Radiol
|
2009
|
0.84
|
|
60
|
Validation of injection parameters for catheter-directed intraarterial gadolinium-enhanced MR angiography.
|
Acad Radiol
|
2002
|
0.82
|
|
61
|
Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
|
J Vasc Interv Radiol
|
2009
|
0.82
|
|
62
|
Quantitative 4D transcatheter intraarterial perfusion MRI for standardizing angiographic chemoembolization endpoints.
|
AJR Am J Roentgenol
|
2011
|
0.82
|
|
63
|
Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma.
|
Acad Radiol
|
2011
|
0.81
|
|
64
|
Cancer concepts and principles: primer for the interventional oncologist-part II.
|
J Vasc Interv Radiol
|
2013
|
0.80
|
|
65
|
Uterine artery embolization: a treatment option for symptomatic fibroids in postmenopausal women.
|
J Vasc Interv Radiol
|
2007
|
0.80
|
|
66
|
Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization.
|
Cardiovasc Intervent Radiol
|
2011
|
0.80
|
|
67
|
A simple fluoroscopic approach to percutaneous transgastric cystgastrostomy with internalized drainage catheter for treatment of pancreatic pseudocysts: report of two cases.
|
Dig Dis Sci
|
2009
|
0.79
|
|
68
|
Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.
|
Future Oncol
|
2007
|
0.79
|
|
69
|
Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction.
|
J Vasc Interv Radiol
|
2010
|
0.79
|
|
70
|
Endovascular stent reconstruction of the inferior vena cava complicated by duodenocaval fistula.
|
Semin Intervent Radiol
|
2011
|
0.79
|
|
71
|
Four-dimensional transcatheter intra-arterial perfusion MR imaging before and after uterine artery embolization in the rabbit VX2 tumor model.
|
J Magn Reson Imaging
|
2010
|
0.78
|
|
72
|
Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments.
|
Cardiovasc Intervent Radiol
|
2008
|
0.78
|
|
73
|
Use of a combined MR imaging and interventional radiology suite for intraprocedural monitoring of uterine artery embolization.
|
J Vasc Interv Radiol
|
2007
|
0.78
|
|
74
|
Cancer concepts and principles: primer for the interventional oncologist-part I.
|
J Vasc Interv Radiol
|
2013
|
0.77
|
|
75
|
Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma.
|
Radiology
|
2014
|
0.77
|
|
76
|
Portal vein imaging and access for transjugular intrahepatic portosystemic shunts.
|
Tech Vasc Interv Radiol
|
2008
|
0.77
|
|
77
|
Hepatic radioembolization complicated by fulminant hepatic failure.
|
Semin Intervent Radiol
|
2011
|
0.76
|
|
78
|
Hepatic radioembolization complicated by abscess.
|
Semin Intervent Radiol
|
2011
|
0.76
|
|
79
|
Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
|
Transplantation
|
2015
|
0.76
|
|
80
|
How to interpret thyroid biopsy results: a three-year retrospective interventional radiology experience.
|
Cardiovasc Intervent Radiol
|
2009
|
0.75
|
|
81
|
Four-dimensional transcatheter intraarterial perfusion MRI monitoring of radiofrequency ablation of rabbit VX2 liver tumors.
|
J Magn Reson Imaging
|
2011
|
0.75
|
|
82
|
Re: endovenous laser ablation of the great saphenous vein with a 980-nm diode laser in continuous mode: early treatment failures and successful repeat treatments.
|
J Vasc Interv Radiol
|
2007
|
0.75
|
|
83
|
Fibromuscular dysplasia and renal transplantation.
|
J Urol
|
2011
|
0.75
|
|
84
|
Direct hepatic artery puncture for transarterial therapy in liver cancer.
|
J Vasc Interv Radiol
|
2010
|
0.75
|
|
85
|
MR imaging evidence of reversal of uterine ischemia after uterine artery embolization for leiomyomata.
|
J Vasc Interv Radiol
|
2006
|
0.75
|